Search

Your search keyword '"Rodrigo-Troyano, A."' showing total 23 results
Start Over Author "Rodrigo-Troyano, A." Publisher european respiratory society
23 results on '"Rodrigo-Troyano, A."'

1. Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study

Author

Manuela Carugati, Stefano Aliberti, Luis Felipe Reyes, Ricardo Franco Sadud, Muhammad Irfan, Cristina Prat, Nilam J. Soni, Paola Faverio, Andrea Gori, Francesco Blasi, Marcos I. Restrepo, Patricia Karina Aruj, Silvia Attorri, Enrique Barimboim, Juan Pablo Caeiro, María I. Garzón, Victor Hugo Cambursano, Adrian Ceccato, Julio Chertcoff, Florencia Lascar, Fernando Di Tulio, Ariel Cordon Díaz, Lautaro de Vedia, Maria Cristina Ganaha, Sandra Lambert, Gustavo Lopardo, Carlos M. Luna, Alessio Gerardo Malberti, Nora Morcillo, Silvina Tartara, Claudia Pensotti, Betiana Pereyra, Pablo Gustavo Scapellato, Juan Pablo Stagnaro, Florencio Varela, Sonali Shah, Felix Lötsch, Florian Thalhammer, Kurt Anseeuw, Camille A. Francois, Eva Van Braeckel, Jean Louis Vincent, Marcel Zannou Djimon, Jules Bashi, Roger Dodo, Simone Aranha Nouér, Peter Chipev, Milena Encheva, Darina Miteva, Diana Petkova, Adamou Dodo Balkissou, Eric Walter Pefura Yone, Bertrand Hugo Mbatchou Ngahane, Ning Shen, Jin-fu Xu, Carlos Andres Bustamante Rico, Ricardo Buitrago, Fernando Jose Pereira Paternina, Jean-Marie Kayembe Ntumba, Vesna Vladic Carevic, Marko Jakopovic, Mateja Jankovic, Zinka Matkovic, Ivan Mitrecic, Marie-Laure Bouchy Jacobsson, Anette Bro Christensen, Uffe Christian Heitmann Bødtger, Christian Niels Meyer, Andreas Vestergaard Jensen, Gertrud Baunbæk-Knudsen, Pelle Trier Petersen, Stine Andersen, Ibrahim El-Said Abd El-Wahhab, Nesreen Elsayed Morsy, Hanaa Shafiek, Eman Sobh, Kedir Abdella Abdulsemed, Fabrice Bertrand, Christian Brun-Buisson, Etienne de Montmollin, Muriel Fartoukh, Jonathan Messika, Pierre Tattevin, Abdo Khoury, Bernard Ebruke, Michael Dreher, Martin Kolditz, Matthias Meisinger, Mathias W. Pletz, Stefan Hagel, Jan Rupp, Tom Schaberg, Marc Spielmanns, Petra Creutz, Norton Suttorp, Beatrice Siaw-Lartey, Katerina Dimakou, Dimosthenis Papapetrou, Evdoxia Tsigou, Dimitrios Ampazis, Evangelos Kaimakamis, Mina Gaga, Mohit Bhatia, Raja Dhar, George D'Souza, Rajiv Garg, Parvaiz A. Koul, P.A. Mahesh, B.S. Jayaraj, Kiran Vishnu Narayan, Hirennappa B. Udnur, Shashi Bhaskara Krishnamurthy, Surya Kant, Rajesh Swarnakar, Sneha Limaye, Sundeep Salvi, Keihan Golshani, Vera M. Keatings, Ignacio Martin-Loeches, Yasmin Maor, Jacob Strahilevitz, Salvatore Battaglia, Maria Carrabba, Piero Ceriana, Marco Confalonieri, Antonella d'Arminio Monforte, Bruno Del Prato, Marino De Rosa, Riccardo Fantini, Giuseppe Fiorentino, Maria Antonia Gammino, Francesco Menzella, Giuseppe Milani, Stefano Nava, Gerardo Palmiero, Roberta Petrino, Barbra Gabrielli, Paolo Rossi, Claudio Sorino, Gundi Steinhilber, Alessandro Zanforlin, Fabio Franzetti, Manuela Morosi, Elisa Monge, Mauro Carone, Vincenzo Patella, Simone Scarlata, Andrea Comel, Kiyoyasu Kurahashi, Zeina Aoun Bacha, Daniel Barajas Ugalde, Omar Ceballos Zuñiga, José F. Villegas, Milic Medenica, E.M.W. van de Garde, Deebya Raj Mihsra, Poojan Shrestha, Elliott Ridgeon, Babatunde Ishola Awokola, Ogonna N.O. Nwankwo, Adefuye Bolanle Olufunlola, Segaolu Olumide, Kingsley N. Ukwaja, Lukasz Minarowski, Skoczyński Szymon, Felipe Froes, Pedro Leuschner, Mariana Meireles, Sofia B Ravara, Victoria Brocovschii, Chesov Ion, Doina Rusu, Cristina Toma, Daniela Chirita, Carmen Mihaela Dorobat, Alexei Birkun, Anna Kaluzhenina, Abdullah Almotairi, Zakeya Abdulbaqi Ali Bukhary, Jameela Edathodu, Amal Fathy, Abdullah Mushira Abdulaziz Enani, Nazik Eltayeb Mohamed, Jawed Ulhadi Memon, Abdelhaleem Bella, Nada Bogdanović, Branislava Milenkovic, Dragica Pesut, Charles Feldman, Ho Kee Yum, Luis Borderìas, Noel Manuel Bordon Garcia, Hugo Cabello Alarcón, Catia Cilloniz, Antoni Torres, Vicens Diaz-Brito, Xavier Casas, Alicia Encabo González, Maria Luisa Fernández-Almira, Miguel Gallego, Inmaculada Gaspar-GarcÍa, Juan González del Castillo, Patricia Javaloyes Victoria, Elena Laserna Martínez, Rosa Malo de Molina, Pedro J. Marcos, Rosario Menéndez, Ana Pando-Sandoval, Cristina Prat Aymerich, Jordi Rello, Silvia Moyano, Francisco Sanz, Oriol Sibila, Ana Rodrigo-Troyano, Jordi Solé-Violán, Ane Uranga, Job F.M. van Boven, Ester Vendrell Torra, Jordi Almirall Pujol, Arnauld Attannon Fiogbe, Ferdaous Yangui, Semra Bilaceroglu, Levent Dalar, Ufuk Yilmaz, Artemii Bogomolov, Naheed Elahi, Devesh J. Dhasmana, Andrew Feneley, Rhiannon Ions, Julie Skeemer, Gerrit Woltmann, Carole Hancock, Adam T. Hill, Banu Rudran, Silvia Ruiz-Buitrago, Marion Campbell, Paul Whitaker, Alexander Youzguin, Anika Singanayagam, Karen S. Allen, Veronica Brito, Jessica Dietz, Claire E. Dysart, Susan M. Kellie, Ricardo A. Franco-Sadud, Garnet Meier, Thomas L. Holland, Stephen P. Bergin, Fayez Kheir, Mark Landmeier, Manuel Lois, Girish B. Nair, Hemali Patel, Katherine Reyes, William Rodriguez-Cintron, Shigeki Saito, Julio Noda, Cecilia I. Hinojosa, Stephanie M. Levine, Luis F. Angel, Antonio Anzueto, K. Scott Whitlow, John Hipskind, Kunal Sukhija, Vicken Totten, Richard G. Wunderink, Ray D. Shah, Kondwelani John Mateyo, Lorena Noriega, Ezequiel Alvarado, Mohamed Aman, and Lucía Labra

Subjects
Medicine
Abstract

This study aimed to describe real-life microbiological testing of adults hospitalised with community-acquired pneumonia (CAP) and to assess concordance with the 2007 Infectious Diseases Society of America (IDSA)/American Thoracic Society (ATS) and 2011 European Respiratory Society (ERS) CAP guidelines. This was a cohort study based on the Global Initiative for Methicillin-resistant Staphylococcus aureus Pneumonia (GLIMP) database, which contains point-prevalence data on adults hospitalised with CAP across 54 countries during 2015. In total, 3702 patients were included. Testing was performed in 3217 patients, and included blood culture (71.1%), sputum culture (61.8%), Legionella urinary antigen test (30.1%), pneumococcal urinary antigen test (30.0%), viral testing (14.9%), acute-phase serology (8.8%), bronchoalveolar lavage culture (8.4%) and pleural fluid culture (3.2%). A pathogen was detected in 1173 (36.5%) patients. Testing attitudes varied significantly according to geography and disease severity. Testing was concordant with IDSA/ATS and ERS guidelines in 16.7% and 23.9% of patients, respectively. IDSA/ATS concordance was higher in Europe than in North America (21.5% versus 9.8%; p

Published
2018
Full Text
View/download PDF

2. Bacteremic pneumococcal pneumonia is associated with an increased rate of cardiovascular events

Author

Antonio Anzueto, Diego Viasus, Ana Maria Rodrigo Troyano, Oriol Vidal, Alejandro Rodríguez, Daiana Stolz, Carlos M. Luna, Luis Alberto Ruiz Iturriaga, Yuichiro Shindo, Marcos I. Restrepo, Leyre Serrano Fernandez, Noemi Borsa, Stefano Aliberti, Francisco Sanz, Ignacio Martin-Loeches, Pedro Pablo España, Jordi Carratalà, and Julio Ramirez

Subjects
medicine.medical_specialty, business.industry, Internal medicine, Pneumococcal pneumonia, medicine, business, medicine.disease
Published
2019
Full Text
View/download PDF

3. Airway FABP4 is decreased in COPD patients with airway bacterial infection

Author

Alvar Agusti, Marian Garcia, Sara Quero, Oriol Sibila, Elisabet Cantó, Rosa Faner, Ferran Sanchez-Reus, Ana Rodrigo-Troyano, Jordi Giner, Marisol Domínguez-Álvarez, Lidia Perea, Eduard Monsó, Judit Villar-García, Alfons Torrego, and Silvia M. Vidal

Subjects
Bronchoalveolar lavage, medicine.medical_specialty, Copd patients, business.industry, Internal medicine, Immunology, medicine, COPD, Airway, business
Published
2019

4. Antimicrobial peptides and airway bacterial colonization in bronchiectasis

Author

Martina Oriano, Ana Rodrigo-Troyano, Lidia Perea, Oriol Sibila Vidal, Stefano Aliberti, Elisabet Cantó, Leonardo Terranova, Silvia Vidal, Jordi Giner, Guillermo Suarez-Cuartin, and James D. Chalmers

Subjects
03 medical and health sciences, 0302 clinical medicine, Bronchiectasis, Bacterial colonization, 030228 respiratory system, business.industry, Antimicrobial peptides, medicine, 030212 general & internal medicine, Airway, medicine.disease, business, Microbiology
Published
2018
Full Text
View/download PDF

6. Predicting hospital readmissions in severe COPD patients using an electronic-nose

Author

A. Alonso, Borja García-Cosío, Diego Sousa, Ana Maria Rodrigo Troyano, Vicente Plaza, Jose Luis Merino, Jordi Giner, Oriol Sibila, Anna Feliu, and Alver Agustí

Subjects
Clinical Practice, COPD, medicine.medical_specialty, Electronic nose, business.industry, Copd patients, Emergency medicine, medicine, Pulmonary disease, After discharge, Severe copd, medicine.disease, business
Abstract

Introduction: Hospital readmissions are critical in the natural history of severe COPD patients. However, its prediction is complicated in clinical practice. The electronic nose is a non-invasive technology capable of distinguish volatile organic compounds (VOC) breath-prints in exhaled breath. Objective: We aim to explore if an electronic nose can reliably predict the presence of future hospital readmissions in admitted patients with Chronic Obstructive Pulmonary Disease (COPD) and frequent severe exacerbations. Methods: Eighty-eight hospitalized COPD patients with two ore more severe exacerbations in the previous year were included. On admission, clinical, functional, microbiological and laboratory data were recorded. During the first 24 hours of admission, exhaled breath was collected in Tedlar bags and VOCs breath-prints were detected by the commercially available electronic nose Cyranose 320®. Cross-validation accuracy was assessed using principal component reduction analysis (PCA). Patients were followed during 90 days after discharge. Results: Seventeen patients (19%) were readmitted at 30-days, and 33 patients (37%) were readmitted at 90-days. No clinical differences on admission were observed among patients who were readmitted or not. However, VOC breath-prints were different among both groups. In predicting 30-day readmission, the accuracy was of 87.5%, sensitivity of 90% and specificity of 76.5% (AUROC 0.85, p Conclusions: An electronic nose may identify admitted severe COPD patients at risk of 30-day and 90-day readmission. Suported by SEPAR, FUCAP.

Published
2018
Full Text
View/download PDF

8. Development of antibiotic-resistance in P. aeruginosa obtained from bronchiectasis patients: a multicenter prospective observational study

Author

Paola Faverio, Francesco Bini, Ana Maria Rodrigo Troyano, Bruno Dino Bodini, Oriol Sibila, Giulia Bonaiti, Anna Stainer, Stefano Carlo Zucchetti, Elisa Franceschi, and Stefano Aliberti

Subjects
03 medical and health sciences, medicine.medical_specialty, 0302 clinical medicine, Bronchiectasis, Antibiotic resistance, 030228 respiratory system, business.industry, Internal medicine, medicine, Observational study, 030212 general & internal medicine, medicine.disease, business
Published
2018
Full Text
View/download PDF

9. Bacteremic pneumococcal pneumonia is associated with an increased rate of cardiovascular events

Author

Borsa, Noemi, primary, Ruiz Iturriaga, Luis A., additional, Serrano Fernandez, Leyre, additional, España, Pedro P., additional, Aliberti, Stefano, additional, Ramirez, Julio A., additional, Sibila Vidal, Oriol, additional, Rodrigo Troyano, Ana M., additional, Rodriguez, Alejandro H., additional, Sanz, Francisco, additional, Shindo, Yuichiro, additional, Martin-Loeches, Ignacio, additional, Luna, Carlos M., additional, Stolz, Daiana, additional, Viasus, Diego, additional, Carratala, Jordi, additional, Anzueto, Antonio R., additional, and Restrepo, Marcos I., additional

Published
2019
Full Text
View/download PDF

10. Airway FABP4 is decreased in COPD patients with airway bacterial infection

Author

Perea, Lídia, primary, Rodrigo-Troyano, Ana, additional, Cantó, Elisabet, additional, Domínguez-Álvarez, Marisol, additional, Giner, Jordi, additional, Sánchez-Reus, Ferran, additional, Torrego, Alfons, additional, Villar-García, Judit, additional, Quero, Sara, additional, Garcia, Marian, additional, Monsó, Eduard, additional, Faner, Rosa, additional, Agustí, Alvar, additional, Vidal, Silvia, additional, and Sibila, Oriol, additional

Published
2019
Full Text
View/download PDF

11. Hospital readmission increases short and long – term mortality in patients with interstitial lung disease after acute respiratory worsening

Author

Guillermo Suarez-Cuartin, Silvia Barril Farre, Oriol Sibila, Anna Feliu, Ivan Castellví, Tomás Franquet, Ana Rodrigo-Troyano, Vicente Plaza, Diego Castillo, and Laura López-Vilaró

Subjects
Hospital readmission, medicine.medical_specialty, business.industry, Emergency medicine, Interstitial lung disease, medicine, In patient, Long term mortality, Respiratory system, medicine.disease, business
Published
2017
Full Text
View/download PDF

12. Antimicrobial peptides and airway bacterial colonization in bronchiectasis

Author

Sibila Vidal, Oriol, primary, Perea, Lídia, additional, Cantó, Elisabet, additional, Suarez-Cuartin, Guillermo, additional, Rodrigo-Troyano, Ana, additional, Terranova, Leonardo, additional, Oriano, Martina, additional, Giner, Jordi, additional, Vidal, Silvia, additional, Aliberti, Stefano, additional, and Chalmers, James D, additional

Published
2018
Full Text
View/download PDF

17. Exacerbations of bronchiectasis requiring hospitalization; clinical characteristics and outcomes

Author

Stefano Aliberti, Ana Rodrigo-Troyano, Diego Castillo, Oriol Sibila, Vicente Plaza, Ferran Sanchez-Reus, Guillermo Suarez-Cuartin, Marcos I. Restrepo, James D. Chalmers, and Anna Feliu

Subjects
medicine.medical_specialty, Bronchiectasis, Exacerbation, business.industry, medicine.disease, University hospital, Natural history, 03 medical and health sciences, Pneumonia, 0302 clinical medicine, 030228 respiratory system, Internal medicine, Hospital discharge, medicine, Observational study, 030212 general & internal medicine, Respiratory system, Intensive care medicine, business
Abstract

INTRODUCTION: Severe exacerbations are key events in the natural history of bronchiectasis. However, data on patients9 characteristics and outcomes is scarce. OBJECTIVE: To assess clinical characteristics and outcomes in hospitalized patients with bronchiectasis exacerbations. METHODS: Prospective observational study conducted on consecutive adults with bronchiectasis admitted to a respiratory ward of a tertiary university hospital because of an exacerbation during 2013-2015. Patients with pneumonia were excluded. RESULTS: Among 60 patients enrolled, median (±SD) age was 74±13 years and FEV1 (% predicted) was 44±17%. Baseline median Bronchiectasis Severity Index was 15 (±4) points and FACED score was 4 (±1). Acute respiratory failure was present in 62% of patients. Length of stay was 8 (±5) days. 10 patients (17%) were readmitted before 30-days of hospital discharge and 20 (34%) before 90-days. Three patients died before 90-days of follow-up. Pseudomonas aeruginosa: (PA) was the most common microorganism isolated in 17 (28%) of the subjects. Patients with PA had lower FEV 1 (37±12% vs. 48±18%, p=0.02), a higher number of exacerbations in the previous year (2.6±2.3 vs. 1.1±1.7, p=0.07) and a higher rate of chronic PA infection (47% vs. 5%, p=0.001) in comparison to those without PA. No differences in clinical outcomes evaluated were found among groups. CONCLUSIONS: Acute exacerbations of bronchiectasis requiring hospitalization affect patients with severe disease and are associated with a higher rate of readmissions. PA is the most common causative microorganism and affects patients with chronic PA colonization and previous exacerbations. However, its presence is not related with worse outcomes.

Published
2016
Full Text
View/download PDF

18. Hospital readmission increases short and long – term mortality in patients with interstitial lung disease after acute respiratory worsening

Author

Barril Farre, Silvia, primary, Rodrigo-Troyano, Ana, additional, Suárez-Cuartín, Guillermo, additional, Feliu, Anna, additional, Franquet, Tomás, additional, López-Vilaró, Laura, additional, Castellví, Iván, additional, Plaza, Vicente, additional, Sibila, Oriol, additional, and Castillo, Diego, additional

Published
2017
Full Text
View/download PDF

20. Acute exacerbations of COPD due topseudomonas aeruginosa: Impact of antimicrobial resistance

Author

Vicente Plaza, Guillermo Suarez-Cuartin, Meritxell Peiro, James D. Chalmers, Oriol Sibila, Ingrid Solanes, Diego Castillo, Ferran Sanchez-Reus, Ana Rodrigo-Troyano, and Marcos I. Restrepo

Subjects
medicine.medical_specialty, COPD, medicine.diagnostic_test, Pseudomonas aeruginosa, medicine.drug_class, business.industry, Antibiotics, medicine.disease_cause, medicine.disease, Sputum culture, Persistence (computer science), Surgery, Antibiotic resistance, Internal medicine, medicine, Sputum, medicine.symptom, Respiratory system, business
Abstract

Introduction: Acute Exacerbations of Chronic Obstructive Pulmonary disease (AECOPD) due to Pseudomonas aeruginosa (PA) are associated with worse outcomes. PA antibiotic resistance is important to determine treatment. Objectives: To study clinical characteristics and outcomes in patients with AECOPD due to PA based on their antibiotic resistance. Methods: Prospective observational study including all patients with AECOPD due to PA admitted in a Respiratory ward in a tertiary hospital in Barcelona during 2013-2014. Resistant PA (PA-R) was defined when ≥1 class of antibiotics were resistant on the antibiogram. Results: 401 patients with AECOPD were evaluated. Of them, 53 (13%) had a positive PA sputum culture. 82% were men, median age (± SD) 77 (±7) years old and FEV1 36 (±17) % of predicted. PA-R was isolated in 35 patients (66%).No differences in demographics, lung function and comorbidities among patients with PA-R and PA-sensible (PA-S) were found, except that patients with PA-R had received more prior oral steroids (80% vs 44%, p = 0.009) and antibiotics (65% vs 33%, p = 0.02) PA persistence after adequate treatment was higher in the PA-R group (82% vs 50%, p = 0.04). However, patients with PA-R had lower 30-day and 90-day mortality when compared to patients with PA –S (3% vs 22%, p = 0.02, and 9% vs 33%, p= 0.02, respectively). Conclusions: PA-R affects patients with severe COPD and previous use of steroids and antibiotics. Persistent PA-R strains were found in follow-up sputum samples. However, the presence of sensitive PA is associated with higher mortality. These results may reflect a contrast between acute infections caused by PA-S and chronic colonization with PA-R.

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results